Cell Cycle Regulators in Stem Cells

Handbook of Stem Cells

Volumn 2, Issue , 2004, Pages 73-82

  Cheng, Tao ^a   Scadden, David T ^b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34250901397     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012436643-5/50096-1     Document Type: Chapter

References (131)

1. Blau H.M., Brazelton T.R., Weimann J.M. The evolving concept of a stem cell: entity or function?. Cell 2001, 105:829-841.
2. D'Urso G., Marraccino R.L., Marshak D.R., Roberts J.M. Cell cycle control of DNA replication by a homologue from human cells of the p34cdc2 protein kinase. Science 1990, 250:786-791.
3. Pardee A.B. G1 events and regulation of cell proliferation. Science 1989, 246:603-608.
4. Sherr C.J. Cancer cell cycles. Science 1996, 274:1672-1677.
5. Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999, 13:1501-1512.
6. Sherr C.J. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 2000, 60:3689-3695.
7. Oostendorp R.A., Audet J., Eaves C.J. Highresolution tracking of cell division suggests similar cell cycle kinetics of hematopoietic stem cells stimulated in vitro and in vivo. Blood 2000, 95:855-862.
8. Pawliuk R., Eaves C., Humphries R.K. Evidence of both ontogeny and transplant dose-regulated expansion of hematopoietic stem cellsin vivo. Blood 1996, 88:2852-2858.
9. Harrison D.E., Lerner C.P. Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil. Blood 1991, 78:1237-1240.
10. Uchida N., Friera A.M., He D., Reitsma M.J., Tsukamoto A.S., Weissman I.L. Hydroxyurea can be used to increase mouse c-kit+Thy-1. 1(lo)Lin-/loSca-1(+) hematopoietic cell number and frequency in cell cycle in vivo. Blood 1997, 90:4354-4362.
11. kip1. Nat. Med. 2000, 6:1235-1240.
12. Cheng T., Rodrigues N., Shen H., Yang Y., Dombkowski D., Sykes M., Scadden D.T. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 2000, 287:1804-1808.
13. Bradford G.B., Williams B., Rossi R., Bertoncello I. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp. Hematol. 1997, 25:445-453.
14. Cheshier S.H., Morrison S.J., Liao X., Weissman I.L. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 1999, 96:3120-3125.
15. Abkowitz J.L.C.S., Guttorp P. Evidence that hematopoiesis may be a stochastic process in vivo. Nat. Med. 1996, 2:190-197.
16. Mahmud N., Devine S.M., Weller K.P., Parmar S., Sturgeon C., Nelson M.C., Hewett T., Hoffman R. The relative quiescence of hematopoietic stem cells in nonhuman primates. Blood 2001, 97:3061-3068.
17. Lemischka I.R., Raulet D.H., Mulligan R.C. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 1986, 45:917-927.
18. Harrison D.E., Astle C.M., Lerner C. Number and continuous proliferative pattern of transplanted primitive immunohematopoietic stem cells. Proc. Natl. Acad. Sci. USA 1988, 85:822-826.
19. Loeffler M., Potten C.S. Stem cells and cellular pedigrees-a conceptual introduction. Stem Cells 1997, 1-27. Academic Press, Cold Spring Harbor, NY. C.S. Potten (Ed.).
20. Quesenberry P.R., Colvin G.A., Lambert J.F. The chiaroscuro stem cell: a unified stem cell theory. Blood 2002, 100:4266-4271.
21. Bonfanti L., Gritti A., Vesscoui A.L. Multipotent stem cells in the adult central nervous system. Stem Cells and CNS Development 2001, 31-48. Humana Press, London. M.S. Rao (Ed.).
22. Palmer T.C. Mobilizing endogenous stem cells. Stem Cells and CNS Development 2001, Human Press, Totowa, NJ. M.S. Rao (Ed.).
23. Doetsch F., Caille I., Lim D.A., Garcia-Verdugo J.M., Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999, 97:703-716.
24. Morshead C.M., Reynolds B.A., Craig C.G., McBurney M.W., Staines W.A., Morassutti D., Weiss S., van der Kooy D. Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells. Neuron 1994, 13:1071-1082.
25. Horner P.J., Gage F.H. Regenerating the damaged central nervous system. Nature 2000, 407:963-970.
26. Dunnwald M., Chinnathambi S., Alexandrunas D., Bickenbach J.R. Mouse epidermal stem cells proceed through the cell cycle. J. Cell Physiol. 2003, 195:194-201.
27. Verfaillie C.M. Hematopoietic stem cells for transplantation. Nat. Immunol. 2002, 3:314-317.
28. Dunbar C.E., Tisdale J., Yu J.M., Soma T., Zujewski J., Bodine D., Sellers S., Cowan K., Donahue R., Emmons R. Transduction of hematopoietic stem cells in humans and in nonhuman primates. Stem Cells 1997, 15(Suppl 1):135-139. discussion 139-140.
29. Wu T., Kim H.J., Sellers S.E., Meade K.E., Agricola B.A., Metzger M.E., Kato I., Donahue R.E., Dunbar C.E., Tisdale J.F. Prolonged high-level detection of retrovirally marked hematopoietic cells in nonhuman primates after transduction of CD34+ progenitors using clinically feasible methods. Mol. Ther. 2000, 1:285-293.
30. Kohn D.B., Hershfield M.S., Carbonaro D., Shigeoka A., Brooks J., Smogorzewska E.M., Barsky L.W., Chan R., Burotto F., Annett G., Nolta J.A., Crooks G., Kapoor N., Elder M., Wara D., Bowen T., Madsen E., Snyder F.F., Bastian J., Muul L., Blaese R.M., Weinberg K., Parkman R. T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nat. Med. 1998, 4:775-780.
31. Peters S.O., Kittler E.L., Ramshaw H.S., Quesenberry P.J. Ex vivo expansion of murine marrow cells with interleukin- 3 (IL-3), IL- 6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 1996, 87:30-37.
32. Orschell-Traycoff C.M., Hiatt K., Dagher R.N., Rice S., Yoder M.C., Srour E.F. Homing and engraftment potential of Sca-1(+)lin(?) cells fractionated on the basis of adhesion molecule expression and position in cell cycle. Blood 2000, 96:1380-1387.
33. Szilvassy S.J., Bass M.J., Van Zant G., Grimes B. Organ-selective homing defines engraftment kinetics of murine hematopoietic stem cells and is compromised by ex vivo expansion. Blood 1999, 93:1557-1566.
34. Conneally E., Cashman J., Petzer A., Eaves C. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic- scid/scid mice. Proc. Natl. Acad. Sci. USA 1997, 94:9836-9841.
35. Miller C.L., Eaves C.J. Expansion in vitro of adult murine hematopoietic stem cells with transplantable lymphomyeloid reconstituting ability. Proc. Natl. Acad. Sci. USA 1997, 94:13648-13653.
36. Ema H., Takano H., Sudo K., Nakauchi H. In vitro self-renewal division of hematopoietic stem cells. J. Exp. Med. 2000, 192:1281-1288.
37. Antonchuk J., Sauvageau G., Humphries R.K. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 2002, 109:39-45.
38. Stier S., Cheng T., Dombkowski D., Carlesso N., Scadden D.T. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood 2002, 99:2369-2378.
39. Varnum-Finney B., Xu L., Brashem-Stein C., Nourigat C., Flowers D., Bakkour S., Pear W.S., Bernstein I.D. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive notch1 signaling. Nat. Med. 2000, 6:1278-1281.
40. Reya T., Duncan A.W., Ailles L., Domen J., Scherer D.C., Willert K., Hintz L., Nusse R., Weissman I.L. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003, 423:409-414.
41. Willert K., Brown J.D., Danenberg E., Duncan A.W., Weissman I.L., Reya T., Yates J.R., Nussem R. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 2003, 423:448-452.
42. Austin T.W., Solar G.P., Ziegler F.C., Liem L., Matthews W. A role for the Wnt gene family in hematopoiesis: Expansion of multilineage progenitor cells. Blood 1997, 89:3624-3635.
43. Broxmeyer H.E., Sherry B., Lu L., Cooper S., Oh K.O., Tekamp-Olson P., Kwon B.S., Cerami A. Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood 1990, 76:1110-1116.
44. Hatzfeld J., Li M.L., Brown E.L., Sookdeo H., Levesque J.P., O'Toole T., Gurney C., Clark S.C., Hatzfeld A. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides. J. Exp. Med. 1991, 174:925-929.
45. Keller J.R., Mantel C., Sing G.K., Ellingsworth L.R., Ruscetti S.K., Ruscetti F.W. Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines. J. Exp. Med. 1988, 168:737-750.
46. Ruscetti F.W., Jacobsen S.E., Birchenall-Roberts M., Broxmeyer H.E., Engelmann G.L., Dubois C., Keller J.R. Role of transforming growth factor-beta 1 in regulation of hematopoiesis. Ann. NY Acad. Sci. 1991, 628:31-43.
47. Keller J.R., McNiece I.K., Sill K.T., Ellingsworth L.R., Quesenberry P.J., Sing G.K., Ruscetti F.W. Transforming growth factor beta directly regulates primitive murine hematopoietic cell proliferation. Blood 1990, 75:596-602.
48. Migdalska A., Molineux G., Demuynck H., Evans G.S., Ruscetti F., Dexter T.M. Growth inhibitory effects of transforming growth factor-beta 1 in vivo. Growth Factors 1991, 4:239-245.
49. Cardoso A.A., Li M.L., Batard P., Hatzfeld A., Brown E.L., Levesque J.P., Sookdeo H., Panterne B., Sansilvestri P., Clark S.C., Hatzfeld J. Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults. Proc. Natl. Acad. Sci. USA 1993, 90:8707-8711.
50. Hatzfeld A., Batard P., Panterne B., Taieb F., Hatzfeld J. Increased stable retroviral gene transfer in early hematopoietic progenitors released from quiescence. Hum. Gene Ther. 1996, 7:207-213.
51. McManus M.T., Sharp P.A. Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 2002, 3:737-747.
52. Hartwell L.H., Weinert T.A. Checkpoints: Controls that ensure the order of cell cycle events. Science 1989, 246:629-634.
53. Vogelstein B.K.K. p53 function and disfunction. Cell 1992, 70:523-526.
54. Sherr C.J. G1 phase progression: cycling on cue. Cell 1994, 79:551-555.
55. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995, 9:1149-1163.
56. Classon M., Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2002, 2:910-917.
57. Bartek J., Lukas J. Pathways governing G1/S transition and their response to DNA damage. FEBS Lett. 2001, 490:117-122.
58. Morgan D.O. Principles of CDK regulation. Nature 1995, 374:131-134.
59. Nakanishi M., Adami G.R., Robetorye R.S., Noda A., Venable S.F., Dimitrov D., Pereira-Smith O.M., Smith J.R. Exit from G0 and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA. Proc. Natl. Acad. Sci. USA 1995, 92:4352-4356.
60. Rivard N., L'Allemain G., Bartek J., Pouyssegur J. Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts. J. Biol. Chem. 1996, 271:18337-18341.
61. Brugarolas J., Chandrasekaran C., Gordon J.I., Beach D., Jacks T., Hannon G.J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 1995, 377:552-557.
62. Nakayama K., Ishida N., Shirane M., Inomata A., Inoue T., Shishido N., Horii I., Loh D.Y., Nakayama K. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996, 85:707-720.
63. Franklin D.S., Godfrey V.L., Lee H., Kovalev G.I., Schoonhoven R., Chen-Kiang S., Su L., Xiong Y. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev. 1998, 12:2899-2911.
64. Conlon I., Raff M. Size control in animal development. Cell 1999, 96:235-244.
65. Cunningham J.J., Roussel M.F. Cyclin-dependent kinase inhibitors in the development of the central nervous system. Cell Growth Differ. 2001, 12:387-396.
66. Cheng T., Scadden D.T. Cell cycle entry of hematopoietic stem and progenitor cells controlled by distinct cyclin- dependent kinase inhibitors. Int. J. Hematol. 2002, 75:460-465.
67. Nabel E.G. CDKs and CKIs: Molecular targets for tissue remodelling. Nat. Rev. Drug Discov. 2002, 1:587-598.
68. Aladjem M.I., Spike B.T., Rodewald L.W., Hope T.J., Klemm M., Jaenisch R., Wahl G.M. ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr. Biol. 1998, 8:145-155.
69. Prost S., Bellamy C.O., Clarke A.R., Wyllie A.H., Harrison D.J. p53-independent DNA repair and cell cycle arrest in embryonic stem cells. FEBS Lett. 1998, 425:499-504.
70. Burdon T., Smith A., Savatier P. Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol. 2002, 12:432-438.
71. Berardi A.C., Wang A., Levine J.D., Lopez P., Scadden D.T. Functional isolation and characterization of human hematopoietic stem cells. Science 1995, 267:104-108.
72. Shen H., Cheng T., Preffer F.I., Dombkowski D., Tomasson M.H., Golan D.E., Yang O., Hofmann W., Sodroski J.G., Luster A.D., Scadden D.T. Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression. J. Virol. 1999, 73:728-737.
73. Becker P.S., Nilsson S.K., Li Z., Berrios V.M., Dooner M.S., Cooper C.L., Hsieh C.C., Quesenberry P.J. Adhesion receptor expression by hematopoietic cell lines and murine progenitors: Modulation by cytokines and cell cycle status. Exp. Hematol. 1999, 27:533-541.
74. Roy V., Verfaillie C.M. Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: implications for anatomical localization and developmental stagespecific regulation of hematopoiesis. Exp. Hematol. 1999, 27:302-312.
75. de Nooij J.C.M.L., Hariharan I.K. A cyclin-dependent kinase inhibitor, Dacapo, is necessary for timely exit from the cell cycleduring Drosphilia embryogenesis. Cell 1996, 87:1237-1247.
76. de Nooij J.C.I.H. Uncoupling cell fate determination from patterned cell division in the Drosphilia eye. Science 1995, 270:983-985. [see comments].
77. Topley G.I., Okuyama R., Gonzales J.G., Conti C., Dotto G.P. p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential. Proc. Natl. Acad. Sci. USA 1999, 96:9089-9094.
78. Durand B., Fero M.L., Roberts J.M., Raff M.C. p27kip1 alters the response of cells to mitogen and is part of a cell-intrinsic timer that arrests the cell cycle and initiates differentiation. Curr. Biol. 1998, 8:431-440.
79. Lowenheim H., Furness D.N., Kil J., Zinn C., Gultig K., Fero M.L., Frost D., Gummer A.W., Roberts J.M., Rubel E.W., Hackney C.M., Zenner H.P. Gene disruption of p27(Kip1) allows cell proliferation in the postnatal and adult organ of corti. Proc. Natl. Acad. Sci. USA 1999, 96:4084-4088.
80. Levine E.M., Close J., Fero M., Ostrovsky A., Reh T.A. p27(Kip1) regulates cell cycle withdrawal of late multipotent progenitor cells in the mammalian retina. Dev. Biol. 2000, 219:299-314.
81. Taniguchi T., Endo H., Chikatsu N., Uchimaru K., Asano S., Fujita T., Nakahata T., Motokura T. Expression of p21(Cip1/Waf1/Sdi1) and p27(Kip1) cyclin-dependent kinase inhibitors during human hematopoiesis. Blood 1999, 93:4167-4178.
82. Yaroslavskiy B., Watkins S., Donnenberg A.D., Patton T.J., Steinman R.A. Subcellular and cell-cycle expression profiles of CDK-inhibitors in normal differentiating myeloid cells. Blood 1999, 93:2907-2917.
83. Tschan M.P., Peters U.R., Cajot J.F., Betticher D.C., Fey M.F., Tobler A. The cyclin-dependent kinase inhibitors p18INK4c and p19INK4d are highly expressed in CD34+progenitor and acute myeloid leukaemic cells but not in normal differentiated myeloid cells. Br. J. Haematol. 1999, 106:644-651.
84. Marone M., Pierelli L., Mozzetti S., Masciullo V., Bonanno G., Morosetti R., Rutella S., Battaglia A., Rumi C., Mancuso S., Leone G., Giordano A., Scambia G. High cyclin-dependent kinase inhibitors in Bcl-2 and Bcl-xL-expressing CD34+-proliferating haematopoietic progenitors. Br. J. Haematol. 2000, 110:654-662.
85. Cheng T., Shen H., Rodrigues N., Stier S., Scadden D.T. Transforming growth factor beta 1 mediates cell-cycle arrest of primitive hematopoietic cellsindependent of p21(Cip1/Waf1) or p27(Kip1). Blood 2001, 98:3643-3649.
86. Stier S.C.T., Forkert R., Lutz C., Dombkowski D.M., Zhang J.L., Scadden D.T. Ex vivo targeting of p21Cip1/Waf1 permits relative expansion of human hematopoietic stem cells. Blood 2003, 102:1260-1266.
87. Liu Y., Martindale J.L., Gorospe M., Holbrook N.J. Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res. 1996, 56:31-35.
88. Braun S.E., Mantel C., Rosenthal M., Cooper S., Liu L., Robertson K.A., Hromas R., Broxmeyer H.E. A positive effect of p21cip1/waf1 in the colony formation from murine myeloid progenitor cellsas assessed by retroviralmediated gene transfer. Blood Cells Mol. Dis. 1998, 24:138-148.
89. Labaer J., Garrett M.D., Stevenson L.F., Slingerland J.M., Sandhu C., Chou H.S., Fattaey A., Harlow E. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 1997, 11:847-862.
90. Cheng M., Olivier P., Diehl J.A., Fero M., Roussel M.F., Roberts J.M., Sherr C.J. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D- dependen kinases in murine fibroblasts. EMBO J. 1999, 18:1571-1583.
91. Mantel C., Luo Z., Canfield J., Braun S., Deng C., Broxmeyer H.E. Involvement of p21cip-1 and p27kip-1 in the molecular mechanisms of steel factor-induced proliferative synergy in vitro and of p21cip-1 in the maintenance of stem/progenitor cells in vivo. Blood 1996, 88:3710-3719.
92. Wang J., Walsh K. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 1996, 273:359-361.
93. Steinman R.A., Hoffman B., Iro A., Guillouf C., Liebermann D.A., el-Houseini M.E. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 1994, 9:3389-3396.
94. Steinman R.A., Huang J., Yaroslavskiy B., Goff J.P., Ball E.D., Nguyen A. Regulation of p21(WAF1) expression during normal myeloid differentiation. Blood 1998, 91:4531-4542.
95. Ellisen L.W., Carlesso N., Cheng T., Scadden D.T., Haber D.A. The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of humanhematopoietic progenitor cells. EMBO J. 2001, 20:1897-1909.
96. el-Deiry W.S. p21/p53, cellular growth control and genomic integrity. Curr. Top. Microbiol. Immunol. 1998, 227:121-137.
97. el-Deiry W.S., Kern S.E., Pietenpol J.A., Kinzler K.W., Vogelstein B. Definition of a consensus binding site for p53. Nat. Genet. 1992, 1:45-49.
98. Hirabayashi Y., Matsuda M., Aizawa S., Kodama Y., Kanno J., Inoue T. Serial transplantation of p53-deficient hemopoietic progenitor cells to assess their infinite growth potential. Exp. Biol. Med. (Maywood) 2002, 227:474-479.
99. Wlodarski P., Wasik M., Ratajczak M.Z., Sevignani C., Hoser G., Kawiak J., Gewirtz A.M., Calabretta B., Skorski T. Role of p53 in hematopoietic recovery after cytotoxic treatment. Blood 1998, 91:2998-3006.
100. Tong X., Srour E.F. TGF-b suppresses cell division of Go CD34+ cells while maintaining primitive hematopoietic potential. Exp. Hematol. 1998, 26:684.
101. Dao M.A., Taylor N., Noltam J.A. Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells. Proc. Natl. Acad. Sci. USA 1998, 95:13006-13011.
102. Coats S., Flanagan W.M., Nourse J., Roberts J.M. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 1996, 272:877-880.
103. Kiyokawa H., Kineman R.D., Manova-Todorova K.O., Soares V.C., Hoffman E.S., Ono M., Khanam D., Hayday A.C., Frohman L.A., Koff A. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27 (Kip1). Cell 1996, 85:721-732.
104. Fero M.L., Rivkin M., Tasch M., Porter P., Carow C.E., Firpo E., Polyak K., Tsai L.H., Broudy V., Perlmutter R.M., Kaushansky K., Roberts J.M. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 1996, 85:733-744.
105. Karnezis A.N., Dorokhov M., Grompe M., Zhu L. Loss of p27(Kip1) enhances the transplantation efficiency of hepatocytes transferred into diseased livers. J. Clin. Invest. 2001, 108:383-390.
106. Doetsch F., Verdugo J.M., Caille I., Alvarez-Buylla A., Chao M.V., Casaccia-Bonnefil P. Lack of the cell-cycle inhibitor p27Kip1 results in selective increase of transitamplifying cellsfor adult neurogenesis. J. Neurosci. 2002, 22:2255-2264.
107. Jacks T., Fazeli A., Schmitt E.M., Bronson R.T., Goodell M.A., Weinberg R.A. Effects of an Rb mutation in the mouse. Nature 1992, 359:295-300.
108. Lee E.Y., Chang C.Y., Hu N., Wang Y.C., Lai C.C., Herrup K., Lee W.H., Bradley A. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 1992, 359:288-294.
109. Clarke A.R., Maandag E.R., van Roon M., van der Lugt N.M., van der Valk M., Hooper M.L., Berns A., te Riele H. Requirement for a functional Rb-1 gene in murine development. Nature 1992, 359:328-330.
110. Park I.K., Qian D., Kiel M., Becker M.W., Pihalja M., Weissman I.L., Morrison S.J., Clarke M.F. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003, 423:302-305.
111. Forkert R.C.T., Sharpless N.E., Adams G.B., Rodrigues N.E., Depinho R.A., Scadden D.T. Cyclin dependent kinase inhibitor, p16INK4a, differentially affects hematopoietic stem cellsunder homeostatic versus stress conditions. The American Society of Hematology 2002.
112. Franklin D.S., Godfrey V.L., O'Brien D.A., Deng C., Xiong Y. Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumorgrowth with distinct tissue specificity. Mol. Cell Biol. 2000, 20:6147-6158.
113. Bai F., Pei X.H., Godfrey V.L., Xiong Y. Haploinsufficiency of p18(INK4c) sensitizes mice to carcinogen-induced tumorigenesis. Mol. Cell Biol. 2003, 23:1269-1277.
114. Yuan Y., Shen H., Franklin D.S., Scadden D.T., Cheng T. In vivo self-renewing divisions of hematopoietic stem cells are increased in the absence of one early G1-phase inhibitor, p18INK4C. Nat. Cell. Biol. 2004, 6:436-442.
115. Dao M.A., Hwa J., Nolta J.A. Molecular mechanism of transforming growth factor beta-mediated cell-cycle modulation in primary human CD34(+) progenitors. Blood 2002, 99:499-506.
116. Qui J., Takagi Y., Harada J., Teramoto T., Rodrigues N., Moskowitz M., Scadden D.T., Cheng T. Regenerative response in ischemic brain restricted by p21cipl/waf1. J. Exp. Med. 2004, 199:937-945.
117. Keller J.R., Jacobsen S.E., Sill K.T., Ellingsworth L.R., Ruscetti F.W. Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor. Proc. Natl. Acad. Sci. USA 1991, 88:7190-7194.
118. Jacobsen S.E., Ruscetti F.W., Dubois C.M., Lee J., Boone T.C., Keller J.R. Transforming growth factor-beta transmodulates the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines. Blood 1991, 77:1706-1716.
119. Massague J., Blain S.W., Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000, 103:295-309.
120. Massague J., Chen Y.G. Controlling TGF-beta signaling. Genes Dev. 2000, 14:627-644.
121. Fortunel N.O., Hatzfeld A., Hatzfeld J.A. Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis. Blood 2000, 96:2022-2036.
122. Cashman J.D., Clark-Lewis I., Eaves A.C., Eaves C.J. Differentiation stage-specific regulation of primitive human hematopoietic progenitor cycling by exogenous and endogenous inhibitors in an in vivo model. Blood 1999, 94:3722-3729.
123. Datto M.B., Li Y., Panus J.F., Howe D.J., Xiong Y., Wang X.F. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 1995, 92:5545-5549.
124. Landesman Y., Bringold F., Milne D.D., Meek D.W. Modifications of p53 protein and accumulation of p21 and gadd45 mRNA in TGF-beta 1 growth inhibited cells. Cell Signal 1997, 9:291-298.
125. Miyazaki M., Ohashi R., Tsuji T., Mihara K., Gohda E., Namba M. Transforming growth factor-beta 1 stimulates or inhibits cell growth via down- or up- regulation of p21/Waf1. Biochem. Biophys. Res. Commun. 1998, 246:873-880.
126. Li C.Y., Suardet L., Little J.B. Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect. J. Biol. Chem. 1995, 270:4971-4974.
127. Elbendary A., Berchuck A., Davis P., Havrilesky L., Bast R.C., Iglehart J.D., Marks J.R. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ. 1994, 5:1301-1307.
128. Ducos K., Panterne B., Fortunel N., Hatzfeld A., Monier M.N., Hatzfeld J. p21(cip1) mRNA is controlled by endogenous transforming growth factor-beta1 in quiescent human hematopoietic stem/progenitor cells. J. Cell Physiol. 2000, 184:80-85.
129. Scandura J.M.B., Nimer S.D. TGFb induced growth arrest of human hematopoietic cells requires p57KIP2 upregulation. The American Society of Hematology 2002.
130. Carlesso N., Aster J.C., Sklar J., Scadden D.T. Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics. Blood 1999, 93:838-848.
131. Sarmento L.C.M., Scadden D.T., Carlesso N. Notch promotes cell cycle entry by decreasing the CDK inhibitors P21cip1 and P27kip1. The American Society of Hematology 2001.